Michael M. Goldberg
2018
In 2018, Michael M. Goldberg earned a total compensation of $1.5M as President and Chief Executive Officer at Navidea Biopharmaceuticals, a 76% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $225,000 |
|---|---|
| Salary | $250,000 |
| Other | $1,017,722 |
| Total | $1,492,722 |
Goldberg received $1M in other compensation, accounting for 68% of the total pay in 2018.
Goldberg also received $225K in non-equity incentive plan and $250K in salary.
Rankings
In 2018, Michael M. Goldberg's compensation ranked 7,186th out of 14,244 executives tracked by ExecPay. In other words, Goldberg earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,186 out of 14,244 | 50th |
Division Manufacturing | 2,775 out of 5,765 | 52nd |
Major group Chemicals And Allied Products | 1,043 out of 2,128 | 51st |
Industry group Drugs | 880 out of 1,817 | 52nd |
Industry In Vitro and In Vivo Diagnostic Substances | 24 out of 72 | 67th |
Source: SEC filing on June 28, 2019.
Goldberg's colleagues
We found four more compensation records of executives who worked with Michael M. Goldberg at Navidea Biopharmaceuticals in 2018.